tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

China Shineway Pharmaceutical Schedules Board Meeting for Interim Results

Story Highlights
China Shineway Pharmaceutical Schedules Board Meeting for Interim Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has shared an announcement.

China Shineway Pharmaceutical Group Limited has announced a board meeting scheduled for 27 August 2025. The meeting will address the approval of the company’s interim results for the first half of 2025 and the consideration of a dividend declaration, reflecting the company’s ongoing financial management and potential shareholder returns.

More about China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It is involved in the production and distribution of pharmaceutical products, serving a diverse market with a range of healthcare solutions.

Average Trading Volume: 1,089,005

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$6.25B

For an in-depth examination of 2877 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1